<?xml version="1.0" encoding="UTF-8"?>
<p>Allergen-specific immunotherapy (AIT), including subcutaneous immunotherapy (SCIT) and sublingual immunotherapy (SLIT), is widely applied to patients with asthma or AR in Asia.
 <xref rid="B19" ref-type="bibr">19</xref>
 <xref rid="B20" ref-type="bibr">20</xref>
 <xref rid="B21" ref-type="bibr">21</xref>
 <xref rid="B22" ref-type="bibr">22</xref> AIT, especially SCIT, requires long-term regular contacts between HCWs and patients (&gt;3 years). During the COVID-19 pandemic, home isolation strategy is necessary to control this highly contagious disease, and frequent hospital visits may increase the risk of exposure to the virus.
</p>
